Mapping Gender Differences in Cardiovascular Disease and Diabetes Care

A Pilot Assessment of LDL Cholesterol Testing Rates in a California Health Plan

by Chloe E. Bird, Allen Fremont, Mark Alan Hanson

Download eBook for Free

Full Document

FormatFile SizeNotes
PDF file 1 MB

Use Adobe Acrobat Reader version 10 or higher for the best experience.

Summary Only

FormatFile SizeNotes
PDF file 0.3 MB

Use Adobe Acrobat Reader version 10 or higher for the best experience.

Despite improvements over recent decades in care for cardiovascular disease (CVD) and diabetes, which is a major CVD risk factor, evidence suggests that the care women receive — and their health outcomes — continue to lag behind those of men, even for routine care, such as monitoring and control of cholesterol. Awareness of and action to address gender gaps in women's CVD care are limited, in part, because quality of care is not routinely measured and reported by gender. This pilot project describes and maps gender differences in CVD and diabetes care using data from a large health plan. The study aims to identify gender gaps in care in California and, where they are found, to increase awareness of potential gender disparities and begin to inform approaches to address gaps in care. The study assesses gender differences in one key aspect of routine CVD care and related prevention among patients with diabetes: low-density lipoprotein (LDL) cholesterol screening. The results from this study are intended to provide the basis for further work to learn and document what it will take to rapidly spread mapping approaches that prove to be helpful in understanding and addressing disparities in health and health care, particularly with regard to improving women's health outcomes. Key findings include that men had higher rates of LDL screening than did women in both the CVD and diabetes populations. These gaps varied by age and insurance type. In addition, mapping gender gaps revealed larger gaps at local levels than were apparent at the state or regional level.

Table of Contents

  • Chapter One

    Introduction

  • Chapter Two

    Methods

  • Chapter Three

    Findings

  • Chapter Four

    Conclusion and Implications

The research described in this report was sponsored by the Barbra Streisand Women's Heart Center at Cedars Sinai Heart Institute and was produced within RAND Health, a division of the RAND Corporation.

This report is part of the RAND Corporation research report series. RAND reports present research findings and objective analysis that address the challenges facing the public and private sectors. All RAND reports undergo rigorous peer review to ensure high standards for research quality and objectivity.

Permission is given to duplicate this electronic document for personal use only, as long as it is unaltered and complete. Copies may not be duplicated for commercial purposes. Unauthorized posting of RAND PDFs to a non-RAND Web site is prohibited. RAND PDFs are protected under copyright law. For information on reprint and linking permissions, please visit the RAND Permissions page.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.